-
admin
Posts
The “Stories of Guangdong” on and off the Court at the Guangdong Basketball Association
GUANGZHOU, China, March 25, 2026 /PRNewswire/ — “To understand Chinese basketball, one must look to Guangdong.” This saying has long circulated widely within China’s basketball community....
NOAH HOLDINGS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER 2025 AND UNAUDITED FINANCIAL RESULTS FOR FULL YEAR 2025
SHANGHAI, March 25, 2026 /PRNewswire/ — Noah Holdings Limited (“Noah” or the “Company”) (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service...
YY Group (NASDAQ: YYGH) Appoints Arros AI Co-Founder Kai Yang as Chief AI Scientist to Accelerate AI-Powered Workforce Platform Development
Appointment Deepens the Company’s AI Capabilities as It Scales Toward Its FY2026 US$103 Million to US$110 Million Revenue Targets SINGAPORE, March 25, 2026 /PRNewswire/ —...
REALTY ONE GROUP NAMED TO ENTREPRENEUR’S FASTEST-GROWING INTERNATIONAL FRANCHISES LIST
The UNBrokerage Continues its Global Momentum, Earning Recognition for Rapid Expansion Beyond U.S. Borders LAGUNA NIGUEL, Calif., March 25, 2026 /PRNewswire/ — Realty ONE Group...
Paranovus Entertainment Technology Limited Announces Pricing of $5 Million Registered Direct Offering At-The-Market Under NASDAQ Rules
NEW YORK, March 25, 2026 /PRNewswire/ — Paranovus Entertainment Technology Limited (NASDAQ: PAVS) today announced that it has entered into a definitive agreement with a...
Beacon Behavioral Partners Welcomes Novus Neurology and SunCoast Psychiatry
Partnerships Expand Access to Advanced Neurological and Psychiatric Care in Florida and Alabama BATON ROUGE, La., March 24, 2026 (GLOBE NEWSWIRE) — Beacon Behavioral Partners...
Press Release Biocartis NV: Biocartis to Collaborate with Medical College of Wisconsin on Breast Cancer Gene Signatures
PRESS RELEASE – 03/24/2026, 08:00 EDT Biocartis to Collaborate with Medical College of Wisconsin on Breast Cancer Gene Signatures Itasca, IL, US, 24 March 2026...
Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis
Oversubscribed financing led by Frazier Life Sciences with participation from F-Prime, Qiming Venture Partners, SR One and founding investors Cambridge Innovation Capital and Cambridge Enterprise...
IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026
LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced...
Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo
Additional analyses from the SCORED and SOTA-P-CARDIA studies provide further evidence of benefits across patient subgroups potentially related to sotagliflozin’s mechanism of action THE WOODLANDS,...
